Brain size reduced in schizophrenia patients

NewsGuard 100/100 Score

By Mark Cowen, Senior medwireNews Reporter

Medicated and antipsychotic-naive patients with schizophrenia show significant reductions in brain volume, researchers report.

In a meta-analysis of data from 317 published studies, the team found that intracranial and total brain volumes were significantly reduced in schizophrenia patients compared with controls, after accounting for age, gender, duration of illness, and other variables.

The findings suggest "a neurodevelopmental origin to some of the brain volume reductions observed in schizophrenia," say Sander Haijma (University Medical Center Utrecht, the Netherlands) and team.

In total, 9098 patients and 9231 mentally healthy controls participated in the studies, which were published between 1998 and 2012.

The team found that medicated schizophrenia patients (n= 8327) had significant intracranial and total brain volume reductions of 2.0% and 2.6%, respectively, compared with controls.

Antipsychotic-naive patients (n=771) also showed significant intracranial and total brain volume reductions compared with controls, at 1.7% and 2.0%, respectively, although the magnitude of such reductions was less than that in medicated patients.

The greatest volume reductions in schizophrenia patients were observed in gray matter structures, although total gray matter reductions were greater in medicated than antipsychotic-naive patients, at 4.3% versus 3.8%.

The researchers note that a longer duration of illness and higher doses of antipsychotic medication were associated with greater gray matter volume reductions among the patients.

They write in Schizophrenia Bulletin: "On the basis of this meta-analysis including over 8000 medicated and nearly 800 medication-naive patients, the conclusion appears warranted that brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes - reflected in intracranial volume reduction - and illness progression."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough brain stimulator could revolutionize treatment for neurological disorders